{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:58:30Z","timestamp":1784998710197,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.beem.2020.101417","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T03:18:05Z","timestamp":1583810285000},"page":"101417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Disease monitoring of Primary Aldosteronism"],"prefix":"10.1016","volume":"34","author":[{"given":"Gian Paolo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Lenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa M.","family":"Seccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2020.101417_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tem.2005.02.010","article-title":"Aldosterone as a cardiovascular risk factor","volume":"16","author":"Rossi","year":"2005","journal-title":"TEM (Trends Endocrinol Metab)"},{"key":"10.1016\/j.beem.2020.101417_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0140-6736(75)91559-7","article-title":"Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?","volume":"1","author":"Padfield","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2020.101417_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.48.3.491","article-title":"Spironolactone as a nonspecific treatment for primary aldosteronism","volume":"XLVIII","author":"Bravo","year":"1973","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2020.101417_bib5","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2020.101417_bib6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","article-title":"Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms)","volume":"58","author":"Mulatero","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101417_bib7","first-page":"1029","article-title":"The biology of normal zona glomerulosa and aldosterone-producing adenoma: pathological implications","volume":"39","author":"Seccia","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2020.101417_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0031-1299730","article-title":"The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience","volume":"44","author":"Pallauf","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2020.101417_bib9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/HYPERTENSIONAHA.118.11150","article-title":"Saga of familial hyperaldosteronism: yet a new channel","volume":"71","author":"Lenzini","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101417_bib10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2020.101417_bib11","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","article-title":"Primary aldosteronism: JACC state-of-the-art review","volume":"74","author":"Rossi","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.beem.2020.101417_bib12","first-page":"1","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"8587","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2020.101417_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101417_bib14","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A\u00a0screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2020.101417_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/HYPERTENSIONAHA.109.139832","article-title":"Within-patient reproducibility of the aldosterone:renin ratio in primary aldosteronism","volume":"55","author":"Rossi","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101417_bib16","article-title":"Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: the Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study","volume":"6","author":"Maiolino","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.beem.2020.101417_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrendo.2011.180","article-title":"Adrenal gland: a diagnostic algorithm - the holy grail of primary aldosteronism","volume":"7","author":"Rossi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2020.101417_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1677\/erc.1.00867","article-title":"Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course","volume":"12","author":"Seccia","year":"2005","journal-title":"Endocr Relat Canc"},{"key":"10.1016\/j.beem.2020.101417_bib19","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S2213-8587(16)30240-6","article-title":"Adrenal vein sampling versus CT scanning in primary aldosteronism","volume":"4","author":"Funder","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2020.101417_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MED.0000000000000407","article-title":"Update in adrenal venous sampling for primary aldosteronism","volume":"25","author":"Rossi","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2020.101417_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/HJH.0000000000001939","article-title":"10 good reasons why adrenal vein sampling is the preferred method for referring primary aldosteronism patients for adrenalectomy","volume":"37","author":"Rossi","year":"2019","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2020.101417_bib22","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101417_bib23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101417_bib24","first-page":"1","article-title":"A\u00a0novel method: super-selective adrenal venous","volume":"2","author":"Makita","year":"2017","journal-title":"Sampling"},{"key":"10.1016\/j.beem.2020.101417_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1148\/radiol.2015142159","article-title":"Intra-adrenal aldosterone secretion: segmental adrenal venous sampling for localization","volume":"278","author":"Satani","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.beem.2020.101417_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-0042-105278","article-title":"Recent developments in primary aldosteronism","volume":"124","author":"Asbach","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.beem.2020.101417_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.12659\/AJCR.913172","article-title":"A\u00a0case of primary aldosteronism due to a primary adrenal adenoma diagnosed by segmental adrenal venous sampling (S-AVS) using a modified catheter system and lateral cine angiography","volume":"20","author":"Okamura","year":"2019","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.beem.2020.101417_bib28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s00270-018-1930-3","article-title":"Image fusion guidance with pre-procedural CT with real-time fluoroscopy for Adrenal Venous Sampling","volume":"41","author":"Morita","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.beem.2020.101417_bib29","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2020.101417_bib30","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2020.101417_bib31","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/0002-9149(88)90264-0","article-title":"Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism","volume":"62","author":"Suzuki","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.beem.2020.101417_bib32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","article-title":"The clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling","volume":"74","author":"Rossi","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101417_bib33","article-title":"Drug-resistant hypertension resolution by adrenal vein sampling-guided adrenalectomy","author":"Torresan","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101417_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12893-018-0432-1","article-title":"Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism","volume":"18","author":"Citton","year":"2019","journal-title":"BMC Surg"},{"key":"10.1016\/j.beem.2020.101417_bib35","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101417_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00423-014-1269-4","article-title":"Outcome of surgical treatment of primary aldosteronism","volume":"400","author":"Citton","year":"2015","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.beem.2020.101417_bib37","first-page":"69","article-title":"Approach to the surgical management of primary aldosteronism","volume":"4","author":"Iacobone","year":"2015","journal-title":"Gland Surg"},{"key":"10.1016\/j.beem.2020.101417_bib38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00268-008-9513-0","article-title":"Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia","volume":"32","author":"Walz","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2020.101417_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneph0151","article-title":"Primary aldosteronism: diagnostic and treatment strategies","volume":"2","author":"Mattsson","year":"2006","journal-title":"Nat Clin Pract"},{"key":"10.1016\/j.beem.2020.101417_bib40","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: primary aldosteronism-- changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2020.101417_bib41","article-title":"Subtyping of primary aldosteronism in the AVIS-2 Study: assessment of selectivity and lateralisation","author":"Rossitto","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101417_bib42","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1067\/msy.1998.93108","article-title":"Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?","volume":"124","author":"Proye","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2020.101417_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.surg.2017.07.034","article-title":"Contralateral suppression of aldosterone at adrenal venous sampling predicts hyperkalemia following adrenalectomy for primary aldosteronism","volume":"163","author":"Shariq","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2020.101417_bib44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/jhh.2017.38","article-title":"Hyperkalemia in both surgically and medically treated patients with primary aldosteronism","volume":"31","author":"Wada","year":"2017","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.beem.2020.101417_bib45","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/000313481708300624","article-title":"Considering postoperative functional hypoaldosteronism after unilateral adrenalectomy","volume":"83","author":"Starker","year":"2017","journal-title":"Am Surg"},{"key":"10.1016\/j.beem.2020.101417_bib46","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(00)03129-9","article-title":"A\u00a0thoracic mass with hypertension and hypokalaemia","volume":"356","author":"Rossi","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2020.101417_bib47","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ando.2016.01.009","article-title":"SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 6: adrenal surgery","volume":"77","author":"Steichen","year":"2016","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.beem.2020.101417_bib48","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","article-title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study","volume":"48","author":"Lim","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.beem.2020.101417_bib49","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1055\/s-0035-1565128","article-title":"Mineralocorticoid receptor antagonists and clinical outcomes in primary aldosteronism: as good as surgery?","volume":"47","author":"Sechi","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2020.101417_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1570161115666170426145612","article-title":"Clinical value of measuring the renin\/aldosterone levels: optimising the management of uncontrolled\/resistant hypertension","volume":"16","author":"Doumas","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.beem.2020.101417_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2020.101417_bib52","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.beem.2020.101417_bib53","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCIMAGING.112.974576","article-title":"Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study","volume":"5","author":"Freel","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.beem.2020.101417_bib54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.HYP.0000023182.68420.EB","article-title":"Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism","volume":"40","author":"Rossi","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101417_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCIMAGING.116.004815","article-title":"Cardiac remodeling in patients with primary and secondary aldosteronism; A tissue Doppler study","volume":"9","author":"Cesari","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.beem.2020.101417_bib56","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101417_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2020.101417_bib58","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention for End point reduction in hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.beem.2020.101417_bib59","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/CIRCULATIONAHA.108.830042","article-title":"Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women","volume":"119","author":"Conen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2020.101417_bib60","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/HYPERTENSIONAHA.111.179713","article-title":"Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men","volume":"59","author":"Erikssen","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101417_bib61","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/HYPERTENSIONAHA.115.05728","article-title":"Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients","volume":"66","author":"Okin","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101417_bib62","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.beem.2020.101417_bib63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/jhh.2017.28","article-title":"Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea","volume":"31","author":"Wolley","year":"2017","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.beem.2020.101417_bib64","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/jhh.2013.32","article-title":"Clinical characteristics of patients with resistant hypertension: the RESIST-POL study","volume":"27","author":"Florczak","year":"2013","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.beem.2020.101417_bib65","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study","volume":"97","author":"Pilz","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101417_bib66","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","article-title":"Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma","volume":"60","author":"Rossi","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101417_bib67","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","article-title":"Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism","volume":"30","author":"Maniero","year":"2012","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2020.101417_bib68","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.2016-3206","article-title":"Primary aldosteronisms a risk factor for vertebral fracture","volume":"102","author":"Notsu","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101417_bib69","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jc.2017-02043","article-title":"Lower trabecular bone score in patients with primary aldosteronism: human skeletal deterioration by aldosterone excess","volume":"103","author":"Kim","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X20300440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X20300440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:55:30Z","timestamp":1761497730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X20300440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1521690X20300440"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2020.101417","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease monitoring of Primary Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2020.101417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101417"}}